Evidence map›Paper›PMID 35284007›Full record

ArticleRevue francophone des laboratoires : RFL2022

[Exploration of vaccine immunogenicity].

Jessica Denis, Marie Mura, Aurélie Trignol, Jean-Nicolas Tournier

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Revue francophone des laboratoires : RFL, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica DenisUnité immunopathologie, Institut de recherche biomédicale des armées, 1 place du général-Valérie-André, 91220 Brétigny-sur-Orge, France.
Marie MuraUnité immunopathologie, Institut de recherche biomédicale des armées, 1 place du général-Valérie-André, 91220 Brétigny-sur-Orge, France.
Aurélie TrignolUnité fatigue et vigilance, Institut de recherche biomédicale des armées, 1 place du général-Valérie-André, 91220 Brétigny-sur-Orge, France.
Jean-Nicolas TournierLaboratoire d'innovation : vaccins, Institut Pasteur, 28 rue du Dr-Roux, 75015 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of new vaccines has traditionally been a long-term job, although recent experience with the emergence of Covid-19 has caused development and production delays to skyrocket. The fact remains that the development of vaccines in the preclinical phases and in phases 1 and 2 of clinical development is based on the study of the specific immune response of the adaptive immune system.

Indexed as

antibodyantigen presenting cellB lymphocyteElisaT lymphocytevaccine

Identifiers

PMID35284007
PMCPMC8896448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.